Singapore – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that Lumify, an ultrasound solution compatible with Android devices, is now available for qualified practitioners or medical organizations in Singapore. Philips’ ultrasound digital health approach connects compatible smart devices, a mobile application, advanced ultrasound transducer technology, integrated IT and support services to help healthcare providers improve patient care and reduce costs.
Lumify, the Philips app-based ultrasound solution, helps healthcare professionals make fast, informed decisions. With Lumify’s full suite of point-of-care transducers, physicians in multiple care situations can take advantage of every crucial moment without the time and mobility restrictions of locating a cart-based ultrasound.
At Philips, we understand the power technology can have for healthcare practitioners and patients, and we design and innovate meaningful solutions to cater to them at the point-of-care”, said Diederik Zeven, General Manager, Health Systems, Philips ASEAN Pacific. “Philips’ vision for app-based ultrasound is focused on putting high-quality devices in the hands of more professionals to serve more patients in more locations. Lumify is further extending the reach of
ultrasound by creating better connections between clinicians and their patients, while continuing to deliver exceptional image quality.”
Diederik Zeven
General Manager, Health Systems, Philips ASEAN Pacific
Lumify is the first Philips ultrasound device for pre-hospital use and supports clinical applications including cardiac, abdominal including lung, OB/GYN, superficial, vascular, soft tissue, MSK, gallbladder and FAST exam pre-sets.
To use Lumify, users download The Lumify App from the Google Play store, connect their Philips transducer to their compatible smart device and launch the app to begin scanning. The Lumify App and all three transducers (L12-4, C5-2, and S4-1) are backed by a 5-year warranty, each having gone through rigorous environmental and durability testing for reliability for any clinical setting. The S4-1 transducer and cable weighs 152 grams and is smaller than a smartphone, adding to its versatility and mobility. Beyond integrating with everyday technology, Lumify also uses cloud-enabled technology to connect with PACS, shared networks and system directories.
Having used a solution like the Philips Lumify device, there are a few aspects that stand out,” said Associate Professor Tan Teng Hong, Head and Senior Consultant, Cardiology Service, Department of Paediatric Subspecialties, KK Women's and Children's Hospital. “This includes its portability, image quality and usability. Pocket-sized devices such as this can be easily used in a variety of environments, providing immediate feedback and also allows for users to receive high quality ultrasound imaging on a compatible smart device without the need for a larger echo machine.”
Associate Professor Tan Teng Hong
Head and Senior Consultant, Cardiology Service, Department of Paediatric Subspecialties, KK Women's and Children's Hospital.
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 70,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
January 07, 2021
December 02, 2020
November 12, 2020
